BioVersys and Shionogi have entered a research and exclusive licence option agreement for the co-development of new ansamycin ...

Summit Therapeutics (NASDAQ:SMMT) stock rose 5% on Thursday while AstraZeneca (NASDAQ:AZN) shares fell 2% following a Bloomberg report that the companies are in discussions for a potential $15 billion ...